<DOC>
	<DOC>NCT01397370</DOC>
	<brief_summary>The purpose of the study is to evaluate the safety and tolerability of multiple ascending oral doses (MAD) of GLPG0492 given to healthy subjects for 14 days compared to placebo, and to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of GLPG0492 after multiple oral administrations.</brief_summary>
	<brief_title>Multiple Ascending Dose Study of GLPG0492 in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>healthy male, age 1850 years body mass index (BMI) between 1829.9 kg/mÂ², inclusive. normal values of testosterone (2.498.36 ng/mL) and LH (1.78.6 U/L) smoking drug or alcohol abuse hypersensitivity to any of the ingredients of the study drug</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
</DOC>